Shanshan Pei

6PUBLICATIONS
75CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMolecular targetsMolecular medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Targeting BLVRB Overcomes Immunosuppression and Potentiates Immunotherapy in Monocytic Acute Myeloid Leukemia.

|Aug 12, 2026
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia.

|Jul 08, 2026
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T-Treated T-cell Lymphoid Malignancies.

|Feb 04, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.

Hailin Zhang, Yueshan Li, Yin Zhao

|May 24, 2024
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium.

Anagha Inguva Sheth, Mark J Althoff, Hunter Tolison

|Jun 26, 2023
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.

Shanshan Pei, Ian T Shelton, Austin E Gillen

Pageof 1

Frequent Collaborators

3 joint publications

He Huang

3 joint publications

Lina Liu

2 joint publications

Ian T Shelton

2 joint publications

Austin E Gillen